Cladribine Therapy in Refractory Celiac Disease With Aberrant T Cells
- 1 November 2006
- journal article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 4 (11) , 1322-1327
- https://doi.org/10.1016/j.cgh.2006.07.007
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Refractory coeliac diseaseBest Practice & Research Clinical Gastroenterology, 2005
- The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responsesProceedings of the National Academy of Sciences, 2003
- Azathioprine and prednisone combination therapy in refractory coeliac diseaseAlimentary Pharmacology & Therapeutics, 2003
- Coeliac disease: changing views on gluten-sensitive enteropathy.Scandinavian Journal of Gastroenterology, 2002
- When is a coeliac a coeliac?European Journal of Gastroenterology & Hepatology, 2001
- Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphomaThe Lancet, 2000
- Cyclosporin in the treatment of adults with refractory coeliac disease—an open pilot studyAlimentary Pharmacology & Therapeutics, 2000
- Enteropathy-Type Intestinal T-Cell Lymphoma: Clinical Features and Treatment of 31 Patients in a Single CenterJournal of Clinical Oncology, 2000
- Successful Treatment of Refractory Sprue with CyclosporineAnnals of Internal Medicine, 1993
- Successful treatment of atypical sprue in an infant with cyclosporineGastroenterology, 1988